Skip to main content

Want a detailed portfolio tracker?

Cellectar Biosciences (CLRB) P/E (2011 - 2026)

Cellectar Biosciences (CLRB) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Cellectar Biosciences (CLRB) P/E is -0.26. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cellectar Biosciences (CLRB)

YearP/EChange
2026-0.26-12.54%
2025-0.30+193.48%
2024-0.10-84.23%
2023-0.64+67.64%
2022-0.38-75.69%
2021-1.57-84.91%
2020-10.42-15.28%
2019-12.30+376.54%
2018-2.58-82.01%
2017-14.35+440.63%
2016-2.65-73.98%
2015-10.20-64.31%
2014-28.58-27.38%
2013-39.36-81.79%
2012-216.13-46.27%
2011-402.24N/A

Comparison Cellectar Biosciences (CLRB) P/E with competitors

Cellectar Biosciences (CLRB) P/E is -0.26.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.66%
NBYStablecoin Development Corp0.00-101.66%
ENLVEnlivex Ltd0.07-128.85%
FGENFibroGen Inc0.24-192.57%
CHRSCoherus Biosciences Inc0.85-427.22%
FBIOFortress Biotech Inc0.95-465.98%
ORMPOramed Pharmaceuticals Inc1.50-679.63%
AGENAgenus Inc3.01-1260.61%
INVAInnoviva Inc3.15-1316.30%
VXRTVaxart Inc3.55-1468.90%
CRMDCorMedix Inc3.63-1499.25%
CVACCureVac N.V.4.45-1814.41%
GLPGGalapagos NV4.86-1973.76%
SRPTSarepta Therapeutics Inc4.88-1982.70%
ABEOAbeona Therapeutics Inc5.39-2177.61%
ABUSArbutus Biopharma Corp5.60-2257.87%
ZVRAZevra Therapeutics Inc5.89-2370.32%
SPROSpero Therapeutics Inc6.23-2501.91%
CGENCompugen Ltd6.31-2534.88%
RIGLRigel Pharmaceuticals6.87-2750.11%
SLXNSilexion Therapeutics Corp7.30-2913.63%
OMEROmeros Corporation9.26-3670.50%
AUPHAurinia Pharmaceuticals Inc9.58-3796.30%
PLXProtalix BioTherapeutics Inc10.89-4299.96%
ACADAcadia Pharmaceuticals Inc11.73-4622.94%
TBPHTheravance Biopharma Inc12.26-4828.72%
ADMAAdma Biologics Inc12.42-4888.89%
HRMYHarmony Biosciences Holdings Inc13.82-5429.57%
SABSSAB Biotherapeutics Inc14.14-5551.43%
NAGENiagen Bioscience Inc14.82-5814.41%
INCYIncyte Corp15.82-6201.75%
REGNRegeneron Pharmaceuticals Inc15.86-6214.90%
PBYIPuma Biotechnology Inc17.32-6777.57%
CPRXCatalyst Pharmaceuticals Inc17.44-6825.23%
EXELExelixis Inc17.54-6863.30%
TGTXTG Therapeutics Inc18.97-7414.01%
MDXGMimedx Group Inc20.55-8025.80%
XOMAXOMA Royalty Corp22.87-8921.55%
ARGXArgen X SE24.30-9470.45%
CTMXCytomX Therapeutics Inc24.82-9672.18%
XOMAOXOMA Royalty Corp25.34-9874.14%
HALOHalozyme Therapeutics Inc25.62-9981.70%
XOMAPXOMA Royalty Corp25.67-9999.60%
VRTXVertex Pharmaceuticals Inc27.99-10896.08%
RPRXRoyalty Pharma plc - Class A28.69-11163.26%
SLNOSoleno Therapeutics Inc29.02-11289.67%
ASNDAscendis Pharma A/S30.09-11702.40%
LGNDLigand Pharmaceuticals Inc - Class B37.91-14720.65%
APLSApellis Pharmaceuticals Inc39.02-15148.41%
BMRNBiomarin Pharmaceutical Inc42.21-16378.86%
KRYSKrystal Biotech Inc45.34-17586.57%
ONCBeiGene Ltd69.54-26918.06%
PHARPharming Group N.V.75.03-29033.39%
TECHBio-Techne Corp101.96-39419.95%
VCELVericel Corp109.92-42490.84%
ALNYAlnylam Pharmaceuticals Inc117.96-45592.89%
GMABGenmab140.29-54202.72%
TLXTelix Pharmaceuticals Ltd162.15-62633.76%
CORTCorcept Therapeutics Inc212.86-82187.88%